Most important finding: Pfizer’s planned bivalent booster vaccines will not be tested for safety or effectiveness before they are rolled out to the public this fall. Key detail leading to finding: Pfizer’s fall 2022 booster will be formulated to respond to two extinct or nearly extinct strains of SARS-CoV-2, may […]